KCT0002181
Not yet recruiting
未知
eoadjuvant chemoradiotherapy vs. chemotherapy alone in locally advanced esophageal squamous cell carcinoma: randomized phase II study
ConditionsNeoplasms
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Neoplasms
- Sponsor
- Seoul National University Hospital
- Enrollment
- 114
- Status
- Not yet recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Histologically diagnosed esophageal squamous cell carcinoma (T1N1,2 or T2\-4aN1\-2, excluding T1N0 \& T2N0\) (RECIST1\.1 can participate without measurable lesion)
- •2\) esophageal cancer with previously not treated with surgery , chemotherapy , or radiation therapy
- •3\) Over 20 years old, under 75 years old
- •4\) ECOG performance status 0, 1
- •5\) Appropriate bone marrow, liver, new function
- •\- Bone marrow function: absolute neutrophil count (ANC) \= 1\.5 x 109 / L, platelet count \= 100 x 109 / L, \- hemoglobin \= 10 g / dL
- •\- liver function: total bilirubin \= 1\.5 x upper normal limit, AST, ALT \= 2\.5 x Upper nomal limit, alkaline phosphatase \= 2\.5 x upper normal limit
- •\- renal function: serum creatinine \= 1\.5 x upper normal limit
- •6\) Appropriate lung function
- •\- FEV1 (1 second forced expiratory volume)\> 50% predicted value, DLCO(Diffusion lung capacity for carbon monoxide)\> 50% predicted value
Exclusion Criteria
- •1\) distant metastasis (M1 stage)
- •2\) cervical esophageal cancer difficult to radical surgery (within18 cm from incisor) or gastric esophageal cancer (\<2 cm from cardia) 3\) Subject with a history of other malignant diseases within the last 3 years (allowed cured skin basal cell carcinoma, cervical intraepithelial cancer, early gastric cancer) 4\) Active infection requiring antibiotic treatment 5\) received chemotherapy 30 days 6\) radiation therapy for chest or mediastinum in past 7\) significant and ascites surgery 8\) Pregnant lactating women 9\) Subjects receiving organ transplants immunosuppressive 10\) peripheral neuropathy NCI CTCAE v.4\.0 grade 2 higher 11\) clinically cardiopulmonary disease (eg, congestive heart failure, symptomatic coronary artery disease, myocardial infarction 6 months, arrhythmia uncontrolled, moderate to severe COPD, etc.) 12\) vascular stenosis 13\) who are not appropriate researchers\>
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Therapy for Cancer at Stomach and Esophagous junctioHealth Condition 1: null- Patients with resectable Carcinoma Gastroesophageal junction without clinical metastasisCTRI/2018/05/013757Dr Shivendra Singh
Not yet recruiting
Phase 3
Phase 3 comparative study of two treatment arms in case of operable carcinoma esophagusHealth Condition 1: C159- Malignant neoplasm of esophagus, unspecifiedHealth Condition 2: C158- Malignant neoplasm of overlappingsites of esophagusCTRI/2024/02/062497TMH TRAC
Not yet recruiting
Phase 2
Adjuvant chemotherapy plus radiation versus chemotherapy alone in stage III-IVA endometrial cancer: a phase II randomized controlled trialEvaluate pelvic recurrent rate and survival outcome in stage III-IVA endometrial cancer who receive adjuvant chemotherapy plus radiation versus chemotherapy aloneendometrial cancerradiationadjuvant treatmentTCTR20240725003Mahidol University75
Not yet recruiting
Phase 3
A clinical trial to compare the effects of Adjuvant Chemoradiotherapy versus Adjuvant Chemotherapy in carcinoma gall bladderHealth Condition 1: C23- Malignant neoplasm of gallbladderCTRI/2023/07/055908All India Institute of Medical Sciences Bhubaneswar
Recruiting
Phase 3
Adjuvant Chemotherapy Versus Radiotherapy For Postoperative Cervical Cancer ; a phase 3 trialPatients with high-recurrent risk, stage IB-IIB cervical cancer after radical hysterectomyCervical cancerJPRN-jRCTs041190042Furusawa Akiko250